참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Lithium Hydroxide | HCID 3939 | — |
| 반응물 | Diisopropylethylamine | HCID 81531 | — |
| 반응물 | Valine methyl ester | HCID 94285 | — |
| 반응물 | Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1) | HCID 9886157 | — |
| 반응물 | 4-[6-(3-Chloro-phenylamino)-pyridazin-3-yl]-benzoic acid | HCID 66615763 | — |
| 용매 | Dimethylformamide | HCID 6228 | — |
| 생성물 | HCID 57899118 | HCID 57899118 | — |
반응 단계
To a solution of 4-[6-(3-Chloro-phenylamino)-pyridazin-3-yl]-benzoic acid (0.10 g, 0.31 mmol, 1.0 equiv) in 2 Ml DMF was added HATU (0.23 g, 0.62 mmol, 2.0 equiv) and N,N-diisopropylethylamine (0.27 Ml, 1.5 mmol, 5.0 equiv). Valine methyl ester (0.062 g, 0.37 mmol, 1.0 equiv) was added as a solid, and the homogeneous solution was allowed to stir at room temperature overnight. To the solution was then added 1 Ml 10% aqueous LiOH, and the mixture was then heated to 55° C. The reactions were then filtered and the purified by reverse-phase HPLC to afford the title compound: 1H NMR (400 MHz, MeOD) δ 0.96 (dd, J=9.35, 6.82 Hz, 6H) 2.21 (dq, J=12.13, 6.82 Hz, 1H) 4.41 (d, J=5.05 Hz, 1H) 6.91 (ddd, J=1.26 Hz, 2.02, 1.01 Hz, 1H) 7-21 (t, J=8.08 Hz, 1H) 7.17 (d, J=9.35 Hz, 1H) 7.48 (dd, J=9.22, 1.14 Hz, 1H) 7.88-8.02 (m, 7H); (M+H)+425.1.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US08835451B2 |
|---|
| 출처 데이터셋 | uspto-grants-2014_09 |
|---|
| ORD ID | ord-715d6600209c4b43a21af7fddffe5c13 |
|---|
| 출처 메모 | uspto-grants-2014_09 |
|---|